Mumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary in UK, Relonchem Limited, has received ...
13hon MSN
Diabetes drug and antihistamine could together repair multiple sclerosis damage, trial finds
A combination of metformin, a common diabetes drug, and clemastine, an antihistamine, can help repair myelin—the protective ...
In a large PPMS population that included older patients and people with more advanced disease, ocrelizumab led to a 30% risk ...
Doctors in Cambridge believe they are “on the brink of a new class of treatments” for multiple sclerosis (MS) after a trial ...
Patients with primary progressive MS more commonly exhibited delays in overall disability progression following treatment with ocrelizumab vs placebo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback